Provided by Tiger Trade Technology Pte. Ltd.

Ionis Pharmaceuticals

43.54
-0.4600-1.05%
Post-market: 43.610.0700+0.16%19:56 EDT
Volume:2.31M
Turnover:100.67M
Market Cap:7.24B
PE:-12.51
High:44.17
Open:44.17
Low:43.24
Close:44.00
52wk High:86.74
52wk Low:43.01
Shares:166.18M
Float Shares:161.92M
Volume Ratio:0.63
T/O Rate:1.43%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.4800
EPS(LYR):-2.3812
ROE:-105.50%
ROA:-12.42%
PB:16.45
PE(LYR):-18.28

Loading ...

Ionis Pharmaceuticals Schedules Webcast on Second-quarter 2026 Results

Reuters
·
Jul 15

Ionis Partner Biogen Presents Phase 2 Celia Data at Aaic Demonstrating Meaningful Clinical Outcomes and Robust Tau Reduction with Diranersen in Early Alzheimer’s Disease

THOMSON REUTERS
·
Jul 14

Ionis Pharmaceuticals is Maintained at Outperform by RBC Capital

Dow Jones
·
Jul 13

Ionis Doses First Patient in Phase 1-2 Trial of Ion337 for Dravet Syndrome

Reuters
·
Jul 13

Ionis Doses First Participant in Phase 1-2 Ascend Study of Ion337 in Dravet Syndrome

THOMSON REUTERS
·
Jul 13

RBC Cuts Price Target on Ionis Pharmaceuticals to $85 From $100, Keeps Outperform Rating

MT Newswires Live
·
Jul 13

Can Biogen Convince Skeptics That Cutting a Rogue Protein Slows Alzheimer's?

Dow Jones
·
Jul 13

Biopharma Pricing Power Seen as Key Swing Factor for Q2 Earnings, BofA Says

MT Newswires Live
·
Jul 11

Movement Alert|Ionis Pharmaceuticals Falls 6.04% in Regular Trading, Aftershock Continues from Phase 3 ATTR-CM Trial Failure

Market Focus
·
Jul 10

H.C. Wainwright trims Ionis price target, says trial failure reaction ‘overdone’

TIPRANKS
·
Jul 10

Ionis Pharmaceuticals Inc : H.c. Wainwright Cuts Target Price to $125 from $130

THOMSON REUTERS
·
Jul 10

Ionis Pharmaceuticals Reaffirms Fiscal 2026 Financial Guidance

MT Newswires Live
·
Jul 10

Ionis Pharmaceuticals Reaffirms 2026 Financial Guidance Outlook

TIPRANKS
·
Jul 10

Ionis Pharmaceuticals - Reaffirms Fy2026 Financial Guidance - SEC Filing

THOMSON REUTERS
·
Jul 10

Barclays Sticks to Their Buy Rating for Ionis Pharmaceuticals (IONS)

TIPRANKS
·
Jul 10

Ionis EVP, Chief Development Officer Holly B. Kordasiewicz Sells 362 Shares Worth $30,516.60

Reuters
·
Jul 10

Top Midday Decliners

MT Newswires Live
·
Jul 10

Ionis Pharmaceuticals is Maintained at Buy by Needham

Dow Jones
·
Jul 10

U.S. Stocks on the Move-natera, Nlight, Micron

Reuters
·
Jul 10

Analysts Are Bullish on These Healthcare Stocks: Natera (NTRA), Ionis Pharmaceuticals (IONS)

TIPRANKS
·
Jul 10